PPD, which has had an office in Serbia since 2003, knows local customs and is connected to regulatory agencies. We can streamline the regulatory process for clinical trial approvals by shortening the time it takes to prepare documents.
Serbia offers shorter regulatory timelines than many other countries in the region as well as experienced investigators. Because principal investigators (PIs) need to be at least associate professors working for academic institutions, the quality of work is high.
Learn about the benefits and challenges of conducting clinical trials in Central and Eastern Europe. Download our white paper.